(Q35193009)

7 August 2017

1 reference

title

Pharmacologic treatment of binge eating disorder (English)

1 reference

7 August 2017

1 reference

1 reference

5

Susan L McElroy

1 reference

7 August 2017

2

James I Hudson

1 reference

7 August 2017

6

Harrison G Pope

1 reference

7 August 2017

3

Justine K Lalonde

1 reference

7 August 2017

4

Lindsay Pindyck

1 reference

7 August 2017

William P Carter

1

1 reference

7 August 2017

publication date

1 January 2003

1 reference

International Journal of Eating Disorders

7 August 2017

published in

1 reference

7 August 2017

volume

34 Suppl

1 reference

7 August 2017

page(s)

S74-88

1 reference

Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects

7 August 2017

cites work

1 reference

7 January 2021

Topiramate use in obese patients with binge eating disorder: an open study.

1 reference

7 January 2021

An open-label trial of sibutramine in obese patients with binge-eating disorder.

1 reference

7 January 2021

A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.

1 reference

7 January 2021

Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression

1 reference

7 January 2021

Weight loss in patients taking felbamate.

1 reference

7 January 2021

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

1 reference

7 January 2021

Sibutramine produces dose-related weight loss

1 reference

7 January 2021

Current concepts in the pharmacological management of obesity

1 reference

7 January 2021

Binge eating and other psychopathology in patients with type II diabetes mellitus

1 reference

7 January 2021

Meta-analysis in clinical trials

1 reference

7 January 2021

Binge eating disorder and obesity

1 reference

7 January 2021

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

1 reference

7 January 2021

Epidemiology of the eating disorders

1 reference

7 January 2021

Multivariate logistic regression for familial aggregation of two disorders. II. Analysis of studies of eating and mood disorders

1 reference

7 January 2021

Family study of affective spectrum disorder

1 reference

7 January 2021

Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial

1 reference

7 January 2021

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

1 reference

7 January 2021

Use of new antiepileptic drugs in the treatment of childhood epilepsy

1 reference

7 January 2021

Approaches to treatment-resistant bipolar affectively ill patients

1 reference

7 January 2021

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression

1 reference

7 January 2021

Bulimia and depression

1 reference

7 January 2021

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

7 January 2021

Guidelines for healthy weight

1 reference

7 January 2021

Identifiers

DOI

10.1002/EAT.10207

1 reference

7 August 2017

1 reference